Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Topical delivery of fluorescence (6-Cf) labeled and radiolabeled (99m-Tc) cisplatin and imiquimod by a dual drug delivery system.

Gupta V, Chuttani K, Mishra AK, Trivedi P.

J Labelled Comp Radiopharm. 2014 May 30;57(6):425-33. doi: 10.1002/jlcr.3201. Epub 2014 May 29.

PMID:
24889134
2.

Development of novel topical drug delivery system containing cisplatin and imiquimod for dual therapy in cutaneous epithelial malignancy.

Gupta V, Dhote V, Paul BN, Trivedi P.

J Liposome Res. 2014 Jun;24(2):150-62. doi: 10.3109/08982104.2013.865216. Epub 2013 Dec 13.

PMID:
24328725
3.
4.

Localized delivery of cisplatin for the effective management of squamous cell carcinoma from protransfersome formulation.

Gupta V, Karthikeyan C, Trivedi P.

Arch Pharm Res. 2012 May;35(5):851-9. doi: 10.1007/s12272-012-0510-3. Epub 2012 May 29.

PMID:
22644852
5.

pH-sensitive polymeric cisplatin-ion complex with styrene-maleic acid copolymer exhibits tumor-selective drug delivery and antitumor activity as a result of the enhanced permeability and retention effect.

Saisyo A, Nakamura H, Fang J, Tsukigawa K, Greish K, Furukawa H, Maeda H.

Colloids Surf B Biointerfaces. 2016 Feb 1;138:128-37. doi: 10.1016/j.colsurfb.2015.11.032. Epub 2015 Nov 23.

PMID:
26674841
6.

Cisplatin-loaded polymer-metal complex micelle with time-modulated decaying property as a novel drug delivery system.

Nishiyama N, Kato Y, Sugiyama Y, Kataoka K.

Pharm Res. 2001 Jul;18(7):1035-41.

PMID:
11496942
7.

Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors.

Ding D, Zhu Z, Liu Q, Wang J, Hu Y, Jiang X, Liu B.

Eur J Pharm Biopharm. 2011 Sep;79(1):142-9. doi: 10.1016/j.ejpb.2011.01.008. Epub 2011 Jan 25.

PMID:
21272637
8.

Fluorescent multi-responsive cross-linked P(N-isopropylacrylamide)-based nanocomposites for cisplatin delivery.

Shakoori Z, Ghanbari H, Omidi Y, Pashaiasl M, Akbarzadeh A, Jomeh Farsangi Z, Rezayat SM, Davaran S.

Drug Dev Ind Pharm. 2017 Aug;43(8):1283-1291. doi: 10.1080/03639045.2017.1313859. Epub 2017 Apr 18.

PMID:
28358256
9.
10.

Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice.

Dou YN, Zheng J, Foltz WD, Weersink R, Chaudary N, Jaffray DA, Allen C.

J Control Release. 2014 Mar 28;178:69-78. doi: 10.1016/j.jconrel.2014.01.009. Epub 2014 Jan 15.

PMID:
24440663
11.

Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.

Yu H, Tang Z, Zhang D, Song W, Zhang Y, Yang Y, Ahmad Z, Chen X.

J Control Release. 2015 May 10;205:89-97. doi: 10.1016/j.jconrel.2014.12.022. Epub 2014 Dec 18.

PMID:
25529533
12.

Efficacy of imiquimod-based transcutaneous immunization using a nano-dispersed emulsion gel formulation.

Stein P, Gogoll K, Tenzer S, Schild H, Stevanovic S, Langguth P, Radsak MP.

PLoS One. 2014 Jul 15;9(7):e102664. doi: 10.1371/journal.pone.0102664. eCollection 2014.

13.

Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.

Nishiyama N, Okazaki S, Cabral H, Miyamoto M, Kato Y, Sugiyama Y, Nishio K, Matsumura Y, Kataoka K.

Cancer Res. 2003 Dec 15;63(24):8977-83.

14.

Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.

Kim JH, Kim YS, Park K, Lee S, Nam HY, Min KH, Jo HG, Park JH, Choi K, Jeong SY, Park RW, Kim IS, Kim K, Kwon IC.

J Control Release. 2008 Apr 7;127(1):41-9. doi: 10.1016/j.jconrel.2007.12.014. Epub 2007 Dec 26.

PMID:
18234388
15.

Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Complex Nanoparticles for Potential Cancer Therapy: Preparation, In Vitro and In Vivo Evaluation.

Yu H, Tang Z, Li M, Song W, Zhang D, Zhang Y, Yang Y, Sun H, Deng M, Chen X.

J Biomed Nanotechnol. 2016 Jan;12(1):69-78.

PMID:
27301173
16.

Preparation and evaluation of a novel liposomal formulation of cisplatin.

Zhou X, Wang J, Wu J, Yang X, Yung BC, Lee LJ, Lee RJ.

Eur J Pharm Sci. 2015 Jan 23;66:90-5. doi: 10.1016/j.ejps.2014.10.004. Epub 2014 Oct 16.

PMID:
25446511
17.

A poly(γ, L-glutamic acid)-citric acid based nanoconjugate for cisplatin delivery.

Xiong Y, Jiang W, Shen Y, Li H, Sun C, Ouahab A, Tu J.

Biomaterials. 2012 Oct;33(29):7182-93. doi: 10.1016/j.biomaterials.2012.06.071. Epub 2012 Jul 15.

PMID:
22795851
18.
19.

Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice.

Júnior AD, Mota LG, Nunan EA, Wainstein AJ, Wainstein AP, Leal AS, Cardoso VN, De Oliveira MC.

Life Sci. 2007 Jan 23;80(7):659-64. Epub 2006 Oct 28.

PMID:
17141809
20.

Radiosensitization by intratumoral administration of cisplatin in a sustained-release drug delivery system.

Ning S, Yu N, Brown DM, Kanekal S, Knox SJ.

Radiother Oncol. 1999 Feb;50(2):215-23.

PMID:
10368046

Supplemental Content

Support Center